Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bluejay Diagnostics (BJDX) Accumulated Expenses (2021 - 2023)

Bluejay Diagnostics' Accumulated Expenses history spans 3 years, with the latest figure at $1.1 million for Q4 2023.

  • On a quarterly basis, Accumulated Expenses rose 33.64% to $1.1 million in Q4 2023 year-over-year; TTM through Dec 2023 was $1.1 million, a 33.64% increase, with the full-year FY2023 number at $1.1 million, up 33.64% from a year prior.
  • Accumulated Expenses hit $1.1 million in Q4 2023 for Bluejay Diagnostics, down from $1.4 million in the prior quarter.
  • Over the last five years, Accumulated Expenses for BJDX hit a ceiling of $1.4 million in Q2 2023 and a floor of $341384.0 in Q4 2021.
  • Historically, Accumulated Expenses has averaged $875696.1 across 3 years, with a median of $849563.5 in 2022.
  • Biggest five-year swings in Accumulated Expenses: soared 144.81% in 2022 and later soared 33.64% in 2023.
  • Tracing BJDX's Accumulated Expenses over 3 years: stood at $341384.0 in 2021, then soared by 144.81% to $835730.0 in 2022, then surged by 33.64% to $1.1 million in 2023.
  • Business Quant data shows Accumulated Expenses for BJDX at $1.1 million in Q4 2023, $1.4 million in Q2 2023, and $863397.0 in Q1 2023.